How Diabetes Affects Fertility in Men and Women

Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels resulting from defects in insulin secretion, insulin action, or both. It affects more than 537 million adults worldwide, according to the International Diabetes Federation, and its prevalence continues to rise. While the well-known complications of diabetes include cardiovascular disease, neuropathy, and kidney damage, its impact on reproductive health and fertility is often underappreciated. For individuals and couples planning to conceive, understanding how diabetes interferes with the reproductive system in both men and women is critical. This article provides an in-depth, evidence-based exploration of the mechanisms, consequences, and management strategies for diabetes-related fertility challenges.

Diabetes is not a single condition but encompasses several types. Type 1 diabetes is an autoimmune disorder that destroys pancreatic beta cells, leading to absolute insulin deficiency. Type 2 diabetes, the most common form, involves insulin resistance and progressive beta-cell dysfunction. Gestational diabetes occurs during pregnancy and typically resolves after delivery, but it increases the risk of future type 2 diabetes and can affect fertility indirectly. All forms of diabetes can impair fertility through hormonal disturbances, vascular damage, oxidative stress, and metabolic dysregulation.

How Diabetes Affects Female Fertility

In women, the reproductive system is exquisitely sensitive to metabolic cues. Blood glucose levels, insulin signaling, and energy balance all influence the hypothalamic-pituitary-ovarian (HPO) axis. When diabetes disrupts this delicate equilibrium, fertility can suffer at multiple stages, from ovulation to implantation and pregnancy maintenance.

Hormonal Imbalances and Menstrual Irregularities

High blood sugar levels can directly interfere with the secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus, as well as luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This results in anovulation or oligo-ovulation, leading to irregular or absent menstrual cycles. Studies have shown that women with poorly controlled diabetes are significantly more likely to report menstrual abnormalities compared to those with good glycemic control. In one large cohort, women with type 1 diabetes had a higher prevalence of menstrual disturbances, including longer cycles and prolonged bleedings, even when compared to healthy controls.

Moreover, insulin resistance, a hallmark of type 2 diabetes, promotes hyperinsulinemia. Excess insulin stimulates the ovaries to produce androgens (such as testosterone), further disrupting follicular development and ovulation. This hormonal chaos makes it difficult to predict ovulation windows and reduces the chance of natural conception.

Association with Polycystic Ovary Syndrome (PCOS)

There is a strong bidirectional relationship between diabetes and polycystic ovary syndrome (PCOS). PCOS affects roughly 8–13% of reproductive-age women and is characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. Women with PCOS have a 2- to 3-fold higher risk of developing type 2 diabetes, even after adjusting for body mass index. Conversely, women with diabetes—especially type 2—are more likely to exhibit PCOS features. The shared pathophysiological thread is insulin resistance. Elevated insulin levels exacerbate ovarian androgen production, which in turn worsens metabolic and reproductive outcomes. This overlap makes fertility management particularly challenging, as both conditions require simultaneous attention to blood sugar, weight, and hormonal balance.

Impact on Ovulation and Egg Quality

Beyond cycle regularity, diabetes can compromise the quality of the oocyte itself. Hyperglycemia creates a toxic environment for the developing egg, increasing oxidative stress and mitochondrial dysfunction within the oocyte. Animal models have shown that elevated glucose levels impair meiotic maturation, cause spindle abnormalities, and elevate rates of apoptosis in ovarian follicles. Human data are more limited but consistent: women with poorly controlled diabetes undergoing in vitro fertilization (IVF) tend to produce fewer mature oocytes and have lower fertilization rates compared to women with normal glycemic control. Furthermore, the endometrium may become less receptive due to glucose-induced inflammation and altered gene expression, reducing the chance of successful implantation.

Risks During Pregnancy

Diabetes does not only affect the ability to conceive; it also poses significant risks once pregnancy is achieved. Poor glycemic control at conception and during early pregnancy is strongly associated with an increased risk of miscarriage. The relative risk of spontaneous abortion can be two to three times higher in women with uncontrolled diabetes compared to those with well-controlled levels. Additionally, hyperglycemia during the first trimester increases the likelihood of major congenital anomalies (such as neural tube defects and cardiac malformations) because glucose is a teratogen that disrupts fetal organogenesis. Later in pregnancy, women with preexisting diabetes are at higher risk for preeclampsia, preterm birth, macrosomia (large birth weight), and stillbirth. For women with gestational diabetes, the risks include excessive fetal growth, neonatal hypoglycemia, and an elevated lifetime risk of developing type 2 diabetes for both mother and child. Therefore, meticulous preconception and prenatal glucose management is nonnegotiable.

Management Strategies for Women

Improving fertility in women with diabetes begins with achieving and maintaining excellent glycemic control. The American Diabetes Association recommends a target hemoglobin A1c below 7% (or as low as safely possible) before attempting pregnancy. For women with type 1 diabetes, this may involve intensive insulin therapy with multiple daily injections or an insulin pump, along with continuous glucose monitoring. For those with type 2 diabetes, weight loss through lifestyle modification can dramatically improve insulin sensitivity and restore ovulation. Metformin is another cornerstone, as it reduces hepatic glucose production, improves peripheral insulin sensitivity, and can restore ovulation in many women with PCOS and type 2 diabetes. Additionally, women should be screened for thyroid dysfunction, which often coexists with diabetes and further impairs fertility. A multidisciplinary team including an endocrinologist, reproductive endocrinologist, and dietitian can create a tailored plan to address both diabetes and fertility goals.

How Diabetes Affects Male Fertility

Male fertility is equally vulnerable to the effects of diabetes. Although the spotlight often shines on female reproductive health, male factors contribute to roughly 50% of infertility cases. Diabetes can impair male fertility through direct damage to sperm, disruption of hormonal axes, and vascular and neurological consequences that interfere with sexual function.

Erectile Dysfunction and Retrograde Ejaculation

Erectile dysfunction (ED) is one of the most common and earliest manifestations of diabetic neuropathy and vasculopathy. Chronic hyperglycemia damages endothelial cells lining the blood vessels, reducing nitric oxide availability and impairing vasodilation necessary for erection. Furthermore, autonomic neuropathy can affect the nerves controlling penile smooth muscle. Studies estimate that men with diabetes are three times more likely to develop ED than their non-diabetic counterparts, and the condition often appears 10–15 years earlier. ED directly affects the ability to achieve or maintain an erection sufficient for intercourse, thereby reducing the frequency of insemination.

Additionally, diabetic autonomic neuropathy can disrupt the coordinated closure of the bladder neck during ejaculation, leading to retrograde ejaculation—a condition in which semen flows backward into the bladder instead of exiting the urethra. This results in a low or absent ejaculate volume, making natural conception difficult. Retrograde ejaculation can sometimes be managed with medications (e.g., alpha-agonists) or by retrieving sperm from urine after ejaculation for use in assisted reproduction.

Impact on Sperm Quality

Diabetes negatively affects nearly every parameter of semen quality. Hyperglycemia induces oxidative stress in the male reproductive tract, generating reactive oxygen species (ROS) that damage sperm DNA, lipids, and proteins. Oxidative stress is a primary driver of sperm DNA fragmentation, which is associated with reduced fertilization rates, poor embryo development, and higher miscarriage rates. A meta-analysis of over 30 studies found that men with diabetes have significantly lower sperm concentration, total sperm count, motility, and normal morphology compared to non-diabetic men. The degree of impairment correlates with glycemic control—men with higher HbA1c levels tend to have worse semen parameters.

Moreover, diabetes can cause leukocytospermia (elevated white blood cells in semen), further increasing oxidative damage. The seminal plasma of diabetic men also shows altered levels of antioxidants and inflammatory cytokines, creating a hostile environment for sperm survival. These changes collectively diminish the fertilizing potential of the sperm, even if the count appears moderate.

Hormonal Changes

Testosterone is the master hormone driving spermatogenesis and male libido. Diabetes is associated with a higher prevalence of hypogonadism (low testosterone), due to combined effects on the hypothalamus, pituitary, and testes. Insulin resistance and leptin dysregulation suppress gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH), leading to reduced testicular stimulation. Additionally, hyperglycemia-induced oxidative stress damages Leydig cells directly, impairing testosterone synthesis. Low testosterone results in diminished sperm production and libido, further complicating conception. Testosterone replacement therapy, however, is contraindicated for men who wish to preserve fertility, because exogenous testosterone suppresses the HPG axis and halts spermatogenesis. Instead, treatment should focus on managing diabetes and using medications like clomiphene citrate or human chorionic gonadotropin to stimulate endogenous testosterone production.

Oxidative Stress and Inflammation

As noted, oxidative stress is a central mechanism in diabetes-related male infertility. Chronic hyperglycemia increases the production of advanced glycation end products (AGEs) and activates pathways such as polyol and hexosamine flux, all of which generate ROS. The testis and epididymis have limited antioxidant defenses, making them especially vulnerable. In addition to damaging sperm DNA, ROS attack the sperm membrane's polyunsaturated fatty acids, impairing membrane fluidity and acrosome reaction capacity. Inflammation also plays a role: elevated levels of pro-inflammatory cytokines (e.g., TNF-α, IL-6) in the seminal plasma of diabetic men correlate with reduced sperm motility and increased DNA fragmentation. These molecular changes highlight the need for antioxidant therapy and strict glucose control as part of male fertility management.

Management Strategies for Men

Men with diabetes who are trying to conceive should aim for glycemic targets similar to those for women: HbA1c below 7% when possible. Improved glucose control can partially reverse some of the damage to sperm quality and erectile function. Lifestyle modifications—regular exercise, a diet low in refined sugars and high in antioxidants (fruits, vegetables, nuts, whole grains), smoking cessation, and moderate alcohol intake—have been shown to improve semen parameters and testosterone levels. Weight loss in overweight or obese men with type 2 diabetes can dramatically improve insulin sensitivity and reverse hypogonadism. Pharmacologically, metformin may improve sperm quality by reducing oxidative stress, although evidence is mixed. For erectile dysfunction, phosphodiesterase type 5 inhibitors (e.g., sildenafil, tadalafil) are effective in many diabetic men, provided that vascular damage is not too advanced. In cases of retrograde ejaculation or severe oligospermia, assisted reproductive technologies such as intracytoplasmic sperm injection (ICSI) can bypass natural barriers.

Shared Factors: How Diabetes Impacts Both Genders

While the reproductive effects of diabetes manifest differently in men and women, there are overlapping mechanisms that contribute to infertility in both sexes.

Weight and Metabolic Syndrome

Obesity is a common comorbidity of type 2 diabetes and independently impairs fertility. Excess adipose tissue alters the balance of sex hormones: in women, it increases estrogen production from androgens, disrupting the menstrual cycle; in men, it aromatizes testosterone to estrogen, lowering free testosterone. Metabolic syndrome—characterized by central obesity, hypertension, dyslipidemia, and insulin resistance—amplifies inflammation and oxidative stress globally, affecting egg and sperm alike. Therefore, weight management is a dual-pronged strategy that benefits both partners.

Medication Side Effects

Some diabetes medications may have unintended effects on fertility. Metformin is generally considered beneficial for fertility in women (especially with PCOS) and may offer antioxidant benefits in men. Insulin itself does not impair fertility negatively; in fact, insulin therapy in type 1 patients can restore menstrual cycles. However, some classes of diabetes drugs—such as sulfonylureas or thiazolidinediones—have been associated with negative effects on sperm quality in animal studies, though human data are limited and often confounded by disease severity. It is essential to consult a healthcare provider before adjusting medications when trying to conceive.

Psychological Stress and Fertility

Living with a chronic disease like diabetes can be stressful, and stress itself is a known contributor to infertility. High cortisol levels can suppress the HPG axis in both men and women, reducing libido and impairing gamete production. The constant demand of diabetes self-management may also lead to burnout, affecting adherence to treatment and lifestyle modifications. Additionally, the experience of infertility can worsen psychological distress, creating a vicious cycle. Integrating mental health support—counseling, stress-reduction techniques, and peer support—into fertility care for individuals with diabetes is increasingly recognized as important.

Improving Fertility Outcomes with Diabetes

Despite the challenges, many individuals with diabetes achieve successful pregnancies with appropriate medical and lifestyle interventions. The key is a proactive, comprehensive approach that starts well before conception.

Preconception Care and Counseling

Both partners should undergo a thorough preconception evaluation. For women, this includes checking HbA1c, assessing for diabetes complications (retinopathy, nephropathy, neuropathy), and ensuring up-to-date vaccinations and folic acid supplementation (at least 400–800 mcg daily, often higher if on metformin). For men, a semen analysis and hormonal profile can identify correctable issues. Preconception counseling should cover the risks of diabetes in pregnancy, the importance of glycemic targets, and strategies for achieving them. The American Diabetes Association and the Centers for Disease Control and Prevention both emphasize that planned pregnancies, with optimization of health before conception, dramatically improve outcomes for both mother and baby.

Blood Sugar Control (A1C Targets)

The single most impactful step to improve fertility is strict glycemic control. For women, the target HbA1c before pregnancy is less than 7% (ideally <6.5% if achievable without severe hypoglycemia). For men, similar targets are associated with better sperm quality and erectile function. Continuous glucose monitoring can provide real-time feedback and help identify patterns that need adjustment. Insulin pumps and smart pen devices offer flexibility for those requiring intensive therapy. It is important to note that improvement in glycemic control takes time—at least 3–4 months before attempting conception—to allow for ovulation normalization and reduction in oxidative stress.

Lifestyle Modifications

Healthy diet and regular physical activity are foundational. For women, a diet rich in low glycemic index foods, fiber, healthy fats, and lean protein supports both glucose stability and hormonal balance. For men, antioxidant-rich foods (berries, leafy greens, nuts, dark chocolate) may reduce sperm DNA damage. Exercise improves insulin sensitivity, reduces visceral fat, and lowers stress. Even moderate physical activity (e.g., brisk walking 30 minutes daily) can yield measurable benefits. Additionally, avoiding smoking and limiting alcohol is crucial, as both worsen diabetes complications and reduce fertility independently.

Assisted Reproductive Technologies (ART)

When natural conception proves difficult despite optimized diabetes management, assisted reproductive technologies are a viable option. Ovulation induction with medications such as clomiphene citrate or letrozole can help women who are anovulatory. Intrauterine insemination (IUI) may be used for couples with unexplained infertility or mild male factor. In vitro fertilization (IVF) with or without intracytoplasmic sperm injection (ICSI) can overcome more severe barriers, such as severe oligospermia or tubal damage. For women with diabetes, careful monitoring of glucose levels during ovarian stimulation is essential, as high estrogen levels can impair insulin sensitivity. Embryo transfer should be planned during a cycle with good glycemic control. Men with retrograde ejaculation or severe sperm abnormalities can benefit from surgical sperm retrieval combined with ICSI.

Multidisciplinary Approach

Given the complexity of diabetes and its diverse effects on reproduction, a team-based approach yields the best results. The team typically includes an endocrinologist to optimize diabetes management, a reproductive endocrinologist to address fertility issues, a registered dietitian for nutritional guidance, a diabetes educator, and a mental health professional. Coordinated care ensures that all aspects of a person's health are addressed simultaneously, minimizing delays and maximizing the chances of a healthy pregnancy.

Conclusion

Diabetes is a significant but manageable factor in infertility for both men and women. The condition disrupts hormonal balance, impairs gamete quality, and causes structural and functional damage to reproductive organs. However, with careful glycemic control, lifestyle changes, and appropriate medical interventions, the negative impact can be greatly reduced. Preconception planning, early referral to specialists, and a multidisciplinary approach are key to successful fertility outcomes. If you or your partner have diabetes and are planning a pregnancy, take the first step by scheduling a comprehensive review with your healthcare team. With modern treatments and a proactive mindset, many couples with diabetes can realize their dream of having a healthy child. For further information, consult the American Diabetes Association, the CDC's Reproductive Health and Diabetes page, and the Mayo Clinic for patient-centered guidance.